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“Take-home” message: long-term ambient PM10 exposure is associated with asthma 
prevalence in three European adult cohorts. 
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ABSTRACT  
We investigated effects of both ambient air pollution and traffic noise on adult asthma 
prevalence, using harmonised data from three European cohort studies established in 2006-
2013 (HUNT3, Lifelines, UK Biobank).  
Residential exposures to ambient air pollution (PM10 and NO2) were estimated by a pan-
European Land Use Regression model for year 2007. Traffic noise for year 2009 was 
modelled at home address by adapting a standardised noise assessment framework 
(CNOSSOS-EU). A cross-sectional analysis of 646,731 participants aged ≥20 years was 
undertaken using DataSHIELD to pool data for individual-level analysis via a ‘compute to 
the data’ approach. Multivariate logistic regression models were fitted to assess effects of 
each exposure on lifetime and current asthma prevalence.  
PM10 or NO2 higher by 10 µg/m
3 was associated with 12.8% (95%CI: 9.5% to 16.3%) and 
1.9% (95%CI: 1.1% to 2.8%) higher lifetime asthma prevalence respectively, independent of 
confounders. Effects were larger in those aged ≥50 years, ever-smokers and less educated 
groups. Noise exposure was not significantly associated with asthma prevalence.   
This study suggests that long-term ambient PM10 exposure is associated with asthma 
prevalence in western European adults. Traffic noise is not associated with asthma 
prevalence, but its potential to impact on asthma exacerbations needs further investigation.                      
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INTRODUCTION  
Asthma is a complex respiratory illness which affects both children and adults. Globally, 
asthma was the 28th leading cause of disability-adjusted life years in 2010[1] and it was 
estimated in 2014 that around 334 million people worldwide have asthma[2]. An increasing 
prevalence of asthma was seen in some parts of the developed world at least until the late 
1990s, after which the temporal trend varied across countries[3] ─ in some regions, the 
asthma epidemic continues to increase in adults[4].  
Some potential risk factors have been identified for these prevalence trends. One is exposure 
to air pollution, which has a role in exacerbations of pre-existing asthma and affects asthma 
morbidity via various mechanistic pathways, including airway hyper-responsiveness, airway 
remodelling, oxidative stress and immune response[5]. However, previous studies are 
inconsistent with respect to the associations between long-term air pollution and asthma 
prevalence[6] and incidence[7]. In adults, some studies reported positive associations 
between self-reported traffic intensity and asthma prevalence, though these findings were not 
supported by analysis of individual modelled exposures to air pollution in the same 
populations[8,9]. Other studies did not report significant associations of air pollution and 
adult asthma prevalence[10-15] except one[16]. A few studies investigated the effect of air 
pollution on adult-onset asthma, with significant associations reported either among all 
participants[17,18], never-smokers[19] or women only[20]. An analysis of six European 
cohorts reported positive but non-significant associations of asthma incidence with a range of 
modelled air pollutants[21].    
Another asthma risk factor is chronic psychosocial stress, which may affect asthma morbidity 
through biological responses and disease management[22]. To our knowledge, there are no 
studies investigating whether individual exposure to traffic noise, generally seen as an 
environmental stressor and mostly co-existing with air pollution in road traffic settings, 
would affect adult asthma morbidity. Only two previous small studies investigated 
associations between subjective noise exposures and asthma prevalence, with null results 
reported[23,24].  
In this study, we investigated the separate and joint effects of both long-term air pollution and 
traffic noise exposure on adult prevalent asthma, using a pooled individual-level analysis of 
harmonised data from three recently established large European cohort studies: HUNT3 
(Norway)[25], Lifelines (the Netherlands)[26] and UK Biobank (United Kingdom)[27].   
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METHODS 
Study populations  
Three cohort studies participating in BioSHaRE (Biobank Standardisation and Harmonisation 
for Research Excellence in the European Union-BioSHaRE-EU) were included in this study.  
HUNT3 is the third survey of the HUNT (Helseundersøkelsen i Nord-Trøndelag) study, 
based in Nord-Trøndelag County in Norway[25]. During 2006-2008, data from 50,805 
residents aged ≥20 years were collected by trained staff. Lifelines is a multi-disciplinary 
prospective population-based cohort study examining in a three-generation design the health 
and health-related behaviours of 167,729 persons living in the North of The Netherlands[26]. 
During baseline recruitment (2006-2013), residents aged 25-50 years and family members 
registered in general practices were randomly invited to participate. Quality-checked data on 
93,277 Lifelines participants were available within the timeframe of this study. UK Biobank, 
established during 2006-2010, recruited 502,649 participants aged 40-69 years across the 
UK[27].       
Exposure assessment  
Ambient air pollution 
Pan-European Land Use Regression (LUR) model at a resolution of 100x100m was used to 
assign annual air pollution estimates at home addresses for each participant from the three 
cohorts[28]. Annual mean NO2 (nitrogen dioxide) and PM10 (Particulate Matter with 
aerodynamic diameter ≤10µm) during 2005-2007 were obtained from over 1500 monitoring 
sites across Europe; means for 2007 were used in the analyses since data for both pollutants 
were available for that year for all three cohorts. Only monitoring sites which captured over 
75% of the total hours for NO2 and days for PM10 were included. The pan-European LUR 
model was developed using 80% of these monitored air pollution data, satellite-based 
ground-level concentrations of NO2 and PM2.5 (Particulate Matter with aerodynamic diameter 
≤2.5µm) on a 10-km grid, land-use and traffic variables obtained from GIS (Geographic 
Information System) (supplement-1). Model performance (explained variance (R2) between 
modelled and measured exposures) for PM10 and NO2 estimates was 36-48% and 46-56% 
respectively, evaluated against the independent subset (20%) of all included monitoring 
sites[28].   
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Additional address level annual estimated NO2 and PM10 concentrations for year 2010 were 
available for Lifelines and UK Biobank, using LUR models for the respective study areas 
from the ESCAPE (European Study of Cohorts for Air Pollution Effects) project[29,30]. R2 
for PM10 and NO2 ESCAPE LUR models was 60-88% and 81-87% respectively, evaluated 
using the leave-one-out cross-validation method[29,30].   
Traffic noise  
We used a simplified version[31], with some lower resolution inputs, of the CNOSSOS-EU 
(Common noise assessment methods in European Union) noise modelling framework[32] to 
estimate noise exposures at address level for participants in each study. In brief, noise sound 
level was estimated for all roads within 500 meters of home address, with consideration of 
noise propagation due to refraction and diffraction, absorption from buildings, distance and 
angle of view. Road network geography, hourly vehicle flows, building heights, land cover 
and meteorological data were obtained for the respective study areas. For participants living 
on minor roads that were not captured in the national level traffic datasets, we assigned a 
fixed low-level baseline flow. Traffic data were for the year of 2009 and land cover data were 
for the year 2006.  
For all three cohorts, we modelled annual mean A-weighted sound pressure level in decibels 
(dB(A)) for day-time noise (Lday, averaged sound level from 07:00 to 19:00) and night-time 
noise (Lnight, averaged sound level from 23:00 to 07:00).  
Harmonisation of covariates and outcomes  
Age, sex, Body Mass Index (BMI), education level (primary school or less, secondary school, 
post-secondary school or above), paid employment (yes or no), smoking (current-, ex- and 
never-smoker), and years at baseline address were harmonised retrospectively across cohorts 
(supplement-2), following a validated protocol[33].  
Lifetime asthma prevalence (“ever-had asthma”) was harmonised based on the self-reported 
answers (yes or no) in study questionnaire (Table 1). “Current-asthma” was defined as a 
self-report of ever-had asthma AND participant reporting asthma-related medication use, for 
which data were ascertained differentially in each cohort (Table 1).  
We did not have information on incident asthma.  
Statistical analyses 
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To overcome the ethico-legal issues associated with physical sharing of data, statistical 
analyses were performed using DataSHIELD[34], a novel tool which allowed co-analysis of 
harmonised datasets across the three participating cohorts without physically sharing the 
individual-level data.  
Firstly, we calculated spearman correlations between metrics of air pollution and noise for 
each cohort. Associations between each metric of air pollution (or noise) and ever and current 
asthma were analysed using multivariate logistic regression. Both air pollution and noise 
metrics were analysed on a continuous scale, assuming a linear effect. Additionally, three 
categories for day-time noise (<55, 55-60, ≥60 dB(A)) and night-time noise (<45, 45-50, ≥50 
dB(A)) were used.       
The covariates were chosen a priori based on current knowledge. The sequence of models 
was as follow: adjusted for study (Model 1), adjusted for study, age and sex (Model 2), 
further adjusted for BMI, smoking, education level and employment status (Model 3). Based 
on Model 3, road traffic noise (or air pollution) were additionally added to the air pollution 
(or noise) model.    
Sensitivity analyses were conducted based on Model 3: a) restricting analyses to those living 
at the same address ≥10 years; b) using ESCAPE-LUR air pollution metrics (PM10 and NO2) 
for Lifelines and UK Biobank instead of the pan-European-LUR metrics; c) conducting 
study-specific analyses and then pooling estimates using meta-analysis methods, in both 
fixed-effect and random-effect models, to explore heterogeneity[35].   
Stratified analyses were conducted based on Model 3 by: i) sex; ii) age <50 or ≥50 years; iii) 
smoking status; iv) BMI <25, 25-30, ≥30 kg/m2; v) education level.   
Individual-level fixed-effect pooled analyses were done in DataSHIELD v4.1.2. Study-level 
meta-analyses were done in Stata v12.1, Texas, USA.  
RESULTS 
Overall, prevalence of ever-had asthma was 11.1% and current-asthma was 4.3% (Table 2). 
Prevalence of ever-had asthma or current-asthma was higher among women, those aged <50 
years, with a BMI over 25kg/m2 and less educated.   
Mean(SD) PM10 ranged from 11(1.1) (HUNT3) to 24(1.7) (Lifelines) µg/m
3 whilst mean NO2 
ranged from 13(3.9) (HUNT3) to 31(10.7) (UK Biobank) µg/m3 (supplement-3). Pooling data 
7 
 
for PM10 and NO2 from 606,657 and 608,102 participants respectively, median and inter-
quartile range (IQR) PM10 was 23 (IQR: 4.3) µg/m
3 ; NO2 29 (IQR: 11.4) µg/m
3 
(supplement-3). In the pooled data, median day-time noise and night-time noise estimates 
were 59 (IQR: 4.3) and 49 (IQR: 4.2) dB(A) respectively.  
Spearman correlations between PM10 and daytime noise ranged from r= 0.04 (HUNT3) to 
0.38 (Lifelines), and between NO2 and day time noise ranged from r= -0.05 (HUNT3) to 0.43 
(Lifelines) (supplement-4). Correlation between NO2 and PM10 was r=0.8 and between 
daytime and night-time noise r=0.99 in each of the three cohorts.   
In all models, statistically significant associations were found for PM10 and NO2 in relation to 
prevalence of ever-had asthma (Table 3). In the fully adjusted Model 3, PM10 higher by 10 
µg/m3 was associated with 12.8% (95%CI: 9.5% to 16.3%) higher prevalence of ever-had 
asthma, and 6.4% (95%CI: 1.2% to 11.9%) higher prevalence of current-asthma. NO2 higher 
by 10 µg/m3 was associated with 1.9% (95%CI: 1.1% to 2.8%) higher prevalence of ever-had 
asthma, but not current-asthma prevalence. Further adjustments for daytime noise did not 
change the associations.  
No associations between categorical or continuous noise exposures and asthma prevalence 
were seen (Table 4 and supplement-5).       
Significant effect modifications (p-value for interaction<0.01) by age, smoking and education 
were observed between PM10 and ever-had asthma prevalence, with stronger associations 
seen for those aged≥50 years, ever-smokers and less educated(Figure 1). Similar findings 
were observed for current-asthma (Supplement-6). No significant effect modifications were 
seen between NO2 and ever-had or current asthma prevalence by any of the studied variables 
(supplement-6).  
In sensitivity analyses, for participants living at the same address for more than 10 years, 
associations between PM10, NO2, and ever-had asthma became slightly stronger (supplement-
7). Using ESCAPE-LUR modelled PM10 and NO2 for Lifelines and UK Biobank instead of 
the pan-European LUR metrics, both ever-had asthma and current-asthma prevalence were 
significantly associated with both PM10 and NO2 (supplement-7).  
Associations between NO2, PM10, daytime noise and ever-had asthma prevalence in Model 3 
assessed via meta-analysis across cohorts (supplementary Figure 1) were similar to those 
from the individual-level analysis. However, study-specific associations between NO2, PM10 
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and current-asthma prevalence were heterogeneous (P<0.05) (supplementary Figure 2) and 
none of the pooled study estimates in the meta-analyses was significant. The effect size in the 
meta-analyses was dominated by UK Biobank.   
DISCUSSION 
In this cross-sectional study involving three large European cohorts, there was a statistically 
significant positive association between ambient PM10 air pollution and both ever-asthma and 
current-asthma prevalence. NO2 was significantly associated with ever-asthma but not 
current-asthma. We found no association between traffic noise exposures and ever or current 
asthma prevalence.  
This study is one of the largest studies of its kind to date. Harmonised exposures and health 
data of over 600,000 participants from three cohorts were brought together for an integrative 
pooled individual-level analysis, using DataSHIELD. Both air pollution and noise exposures 
were modelled at home address, providing an opportunity to investigate health effects of both 
exposures in the same study.     
Previous findings 
Only a few studies have investigated the role of air pollution on adult asthma prevalence, 
with most finding null or weak positive associations. Some used proxy ‘traffic intensity’ 
exposures (e.g. living near a busy road, home distance to a major road) in the analyses and 
reported null associations[11-13,15]. In contrast, two studies found significant associations 
between self-reported traffic exposures near home and increased adult asthma 
prevalence[9,10], but not when using individual modelled home outdoor NO2 or NOx 
(nitrogen oxides). Neither of these two studies examine NO2 or NOx effects on a continuous 
scale. A study of young adult Italians (aged 20-44 years) found that each 18.3 µg/m3 increase 
of NO2 was non-significantly associated with increased asthma prevalence (OR: 1.13, 95%CI: 
0.98 to 1.32)[10]. A national study among 12,177 Australian women reported a null 
association between 3-year mean annual NO2 and asthma prevalence[15].  
In the SAPALDIA study, long-term exposure to PM10 was non-significantly associated with 
increased prevalence of current asthma (OR: 1.19, 95%CI: 0.83 to 1.70) in current 
smokers[14]. Recently, a study of 29,459 Canadian women reported that each 10 µg/m3 
increase of PM2.5 was significantly associated with increased ever-diagnosed asthma 
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prevalence (OR: 1.14, 95%CI: 1.01 to 1.29). Association was stronger among smokers (OR: 
1.58, 95%CI: 1.46 to 1.70), compared to non-smokers (OR: 1.16, 95%CI: 0.96 to 1.41)[16].  
A review of community-level studies in 2013 concluded that there was no evidence of an 
effect of long-term air pollution on asthma prevalence[6], though most of the studies included 
in that review were conducted in children (only two of nine NO2 estimates and one of nine 
PM10 estimates were for adults).  
In contrast to most previous findings, our study suggests that both long-term PM10 and NO2 
exposure is associated with increased lifetime asthma prevalence in adults. By pooling 
individual-level data from three large cohorts, our study has a much larger sample size and 
statistical power to detect an effect. Also, air pollution at home address was modelled at a 
fine spatial scale (100m grid) in our study, contributing to the observed robust associations.        
Whilst findings in the prevalence studies were not entirely consistent, a positive association is 
increasingly suggested between ambient air pollution and incident asthma. In a nationwide 
cohort of U.S women, a borderline significant association between PM2.5 and incident asthma 
was observed (OR: 1.20, 95%CI: 0.99 to 1.46)[20]. However this was not seen in the 
ESCAPE study (OR: 1.04, 95%CI: 0.88 to 1.23)[21]. Two studies reported significant 
associations between NO2 and incident asthma with similar effect sizes[17,18]. In the 
ESCAPE study, NO2 was not associated with asthma incidence (OR: 1.10, 95%CI: 0.99 to 
1.21)[21].  
Effect estimates per 10 µg/m3 were much larger for PM10 than for NO2. There are still 
debates on whether NO2 on its own causes health effects or merely is a marker of traffic-
related, particularly near-road, air pollution[36]. Unlike NO2, particulate matter (PM) air 
pollution is more homogeneous over a wider region, and includes sources other than 
traffic[37]. It was reported that in Europe, PM2.5 accounts for 40-80% of PM10 mass[29]. 
PM2.5, with various substances attached to it, could travel and deposit deep into the 
respiratory tract. These substances, including transitions metals and immunogenic substances, 
could either induce direct airway inflammation or lead to oxidative stress[5], two biological 
pathways linking to asthma. This may explain in part the relatively larger effect estimates 
seen for PM10.  
A recent review concluded that no clear susceptibility factors could be identified to date for 
the link between outdoor air pollution and asthma incidence or prevalence[38]. One of the 
reasons, as the review suggested, may be that most studies lacked statistical power to perform 
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interaction tests. In our study, due to the large sample size, we were able to investigate 
interactions among variables selected a priori. We found stronger associations among those 
aged ≥50 years, ever-smokers and less educated, adding evidence to the scant literature. The 
role of smoking status on the link between air pollution and asthma remains unclear. Some 
previous studies have reported stronger associations among never- and former-smoker[38] 
whilst two recent studies, including the ESCAPE study, observed an association only among 
ever-smokers[16,21]. Different classifications of smoking status were used across previous 
studies, meaning results are not directly comparable. Smokers may have a higher risk for 
asthma[39] and it has been suggested that there may exist a synergistic effect of both tobacco 
smoking and air pollution exposure on asthma[40].    
Asthmatics may move to less-polluted areas (e.g. far from a busy road) because of their 
illness, which could potentially lead to underestimation of the air pollution effects on adult 
asthma prevalence. However, in our study, mean duration of current residence was similar 
between asthmatics (16 years) and non-asthmatics (16.7 years) and adjusting for residence 
years in Model 3 did not change the observed associations, suggesting migration is unlikely 
to have biased these associations. 
Road traffic noise is rarely studied in relation to asthma morbidity. One study found that 
noise annoyance at night, as subjectively reported by 652 children, was significantly 
associated with asthma prevalence among girls[23]. Another study of 1383 middle-aged 
adults reported no association between frequency of intense traffic noise and current asthma 
prevalence[24]. Our much larger study did not find statistically significant associations 
between individual modelled noise exposure and ever-asthma or current asthma prevalence, 
but data were not available to look directly at either asthma incidence or asthma 
exacerbations. It has been hypothesised that road traffic noise, as a psychological stressor, 
may induce alternations in the immune system, increase oxidative stress and disturb sleep, 
which all may potentially result in respiratory exacerbations including asthma[41]. Increasing 
numbers of studies have linked other environmental stressors (e.g. neighbourhood violence, 
deprivation) to asthma morbidity[22], but more studies are needed to investigate the role of 
traffic noise on asthma.      
Limitations        
This study has a number of limitations. First, we adopted a cross-sectional design, which has 
limited value in establishing causal associations. Second, our asthma outcome was not strictly 
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harmonised due to the wording of the original asthma question or variable recording of 
asthma-related medication data. Third, residual confounding cannot be ruled out as we were 
unable to harmonise other potential confounders and effect modifiers across the three cohorts, 
including environmental tobacco smoke, occupational exposures to gases and dust, family 
history of asthma and area-level socioeconomic status. Finally, the modelled air pollution and 
noise estimates inevitably had some exposure misclassifications, although this is unlikely to 
be differential according to the participant’s asthmatic status. Given the broad geographic 
regions that this study covers, we adopted common LUR air pollution and noise models 
developed for Europe to minimise differences between cohorts that would otherwise be 
introduced by having different exposure assessment methods. This study is among the first to 
adapt the CNOSSOS-EU noise framework for epidemiological analysis however traffic flow 
data were not available for some secondary roads, which will lead to underestimation of noise 
levels in those areas. As with most air pollution and noise studies, we used home outdoor, but 
not indoor, air pollution and noise, which may be affected by building type and habits such as 
window opening, leading to further exposure misclassification.  
In conclusion, this large cross-sectional study provides evidence suggesting that long-term 
ambient particulate air pollution, especially PM10, is associated with asthma prevalence in 
western European adults. No associations between traffic noise exposures and asthma 
prevalence were found. Our analyses were conducted using DataSHIELD, a novel ‘compute 
to the data’ approach, which could help maximise the scientific potential of established 
cohorts by pooling personal data robustly yet ethically for research.    
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 Table 1 Information on ever-had asthma and asthma-related medication by each cohort 
 Ever-had asthma Asthma-related medication 
HUNT3 “Have you had or do you 
have any of the following: 
asthma?”  
 “Have you at any time during the last 5 years 
taken medicine for asthma, chronic bronchitis, 
emphysema or COPD?” 
LifeLines “Have you ever had asthma?”  
“If you have ever had asthma, 
was this confirmed by a 
doctor?” 
Asthma-related medication coded under ATC 
(Anatomical Therapeutic Chemical) “R03” (drugs 
for obstructive airway diseases) 
UK 
Biobank 
“Has a doctor ever told you 
that you have had any of the 
following conditions?” 
“Asthma?” 
Participants had asthma-related medication if they 
were currently prescribed an inhaler as ascertained 
via interviews conducted by research nurses. 
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Table 2 Prevalence of ever-had asthma and current asthma by each subgroup for each cohort and for the pooled dataset 
 Ever-had asthma Current-Asthma 
 HUNT3 
(N=50805) 
LifeLines 
(N=93,277) 
UK Biobank 
(N=502,649) 
Pooled  HUNT3 
(N=50805) 
LifeLines 
(N=93,277) 
UK Biobank 
(N=502,649) 
Pooled  
N* 50,783 93,056 500,505 644,344 50,783 93,056 493,157 636,996 
Prevalence 5,953 (11.7%) 7,930(8.5%) 57,911 (11.6%) 71,794 (11.1%) 3,900 (7.7%) 3,954 (4.3%) 19,509 (4.0%) 27,363 (4.3%) 
Sex         
Men 2,575 (11.2%) 3,178 (8.3%) 24,199 (10.6%) 29,952 (10.4%) 1,604 (7.0%) 1,387 (3.6%) 7,707 (3.4%) 10,698 (3.8%) 
Women 3,378 (12.2%) 4,752 (8.7%) 33,712 (12.4%) 41,842 (11.8%) 2,296 (8.3%) 2,567 (4.7%) 11,802 (4.4%) 16,665 (4.7%) 
P-value 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 
Age, years         
<50 years 2,563 (12.0%) 5,933 (9.5%) 15,571 (13.3%) 24,127 (12.0%) 1,568 (7.3%) 2,819 (4.5%) 5,150 (4.5%) 9,537 (4.8%) 
≥50 years 3,390 (11.5%) 1,937 (6.5%) 42,340 (11.1%) 47,667 (10.8%) 2,332 (8.0%) 1,135 (3.8%) 14,359 (3.8%) 17,826 (4.1%) 
P-value 0.11 0.00 0.00 0.00 0.01 0.00 0.00 0.00 
BMI, kg/m2         
<25 1,658 (10.1%) 3,246 (7.7%) 16,961 (10.3%) 21,865 (9.8%) 1,027 (6.2%) 1,497 (3.6%) 5,705 (3.5%) 8,229 (3.7%) 
25-30 2,506 (11.2%) 3,039 (8.3%) 23,404 (11.1%) 28,949 (10.7%) 1,600 (7.2%) 1,523 (4.2%) 7,745 (3.7%) 10,868 (4.1%) 
≥30 1,734 (15.0%) 1,644 (11.4%) 17,207 (14.1%) 20,585 (13.9%) 1,234 (10.7%) 934 (6.5%) 5,977 (5.0%) 8,145 (5.6%) 
P-value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Smoking         
Never 2,156 (10.2%) 3,599 (9.2%) 31,550 (11.6%) 37,305 (11.2%) 1,291 (6.1%) 1,879 (4.8%) 10,544 (3.9%) 13,714 (4.2%) 
Ex 2,098 (13.0%) 2,136 (7.7%) 20,406 (11.8%) 24,640 (11.4%) 1,452 (9.0%) 1,165 (4.2%) 6,832 (4.0%) 9,449 (4.4%) 
Current 1,541 (12.6%) 1,606 (8.1%) 5,697 (10.8%) 8,844 (10.4%) 1,052 (8.6%) 629 (3.2%) 2,031 (3.9%) 3,712 (4.4%) 
P-value 0.00 0.00 0.00 0.00 0.00 0.00 0.33 0.00 
Education         
Lower 1,447 (12.9%) 248 (11.0%) 9,830 (11.6%) 11,525 (11.7%) 1,039 (9.3%) 145 (6.5%) 3,681 (4.4%) 4,865 (5.0%) 
Medium 1,962 (11.7%) 5,225 (8.5%) 11,977 (10.9%) 19,164 (10.2%) 1,247 (7.4%) 2,643 (4.3%) 4,109 (3.8%) 7,999 (4.3%) 
Higher 809 (9.9%) 2,265 (8.4%) 35,027 (11.8%) 38,101 (11.5%) 472 (5.8%) 1,075 (4.0%) 11,343 (3.9%) 12,890 (3.9%) 
P-value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
*Number of participants who had information on asthma. P-value: p-value for chi-square test, significance level at 0.05
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Table 3 Associations (Odds ratio, 95%CI) between ambient air pollution (pan-European LUR modelled PM10 and NO2) and asthma prevalence: pooled 
individual-level analyses from three cohorts  
 PM10 
per 10 µg/m3 
NO2  
per 10 µg/m3 
 N Ever-had asthma N Current asthma N Ever-had asthma N Current asthma 
Model 1 604,414 1.145                         
(1.112 to 1.179) 
597,201 1.063                           
(1.012 to 1.115) 
605,852 1.025                      
(1.017 to 1.033) 
598,627 0.991                          
(0.978 to 1.004) 
Model 2 604,414 1.118                           
(1.085 to 1.151) 
597,201 1.050                           
(1.000 to 1.102) 
605,852 1.019                     
(1.011 to 1.027) 
598,627 0.988                          
(0.975 to 1.001) 
Model 3 566,175 1.128                            
(1.095 to 1.163) 
559,245 1.064                           
(1.012 to 1.119) 
567,485 1.019                            
(1.011 to 1.028) 
560,543 0.988                          
(0.975 to 1.002) 
Model 3 
+day-time noise* 
562,706 1.131                           
(1.097 to 1.166) 
555,776 1.067                      
(1.015 to 1.123) 
564,014 1.020                     
(1.011 to 1.028) 
557,072 0.988                        
(0.974 to 1.002) 
Model1: adjusted for study; Model 2: adjusted for study, sex, age; Model 3: further adjusted for education, employment status, smoking status and body mass 
index. *Day-time (07:00-19:00) continuous noise level in dB(A). 
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Table 4 Associations (Odds ratio, 95%CI) between categorical day-time noise, night-time noise and asthma prevalence in Model 3: pooled individual-level 
analyses from three cohorts  
  Model 3  Model 3+PM10 Model 3 +NO2  
 N# Ever-had asthma Current asthma Ever-had asthma Current asthma Ever-had asthma Current asthma 
Day-time noise, 
dB(A) 
       
<55* 393,949 1 1 1 1 1 1 
55-60 158,700 0.991 
(0.972 to 1.011) 
0.988 
(0.957 to 1.019) 
0.988          
(0.968 to 1.007) 
0.990          
(0.959 to 1.021) 
0.991 
(0.972 to 1.010) 
0.994          
(0.963 to 1.026) 
≥60 63,001 1.013 
(0.986 to 1.042) 
0.990 
(0.947 to 1.036) 
1.005          
(0.977 to 1.033) 
0.985          
(0.941 to 1.031) 
1.010 
(0.982 to 1.038) 
0.999          
(0.955 to 1.045) 
Night-time 
noise, dB(A) 
       
<45* 282,647 1 1 1 1 1 1 
45-50 254,843 0.991 
(0.973 to 1.009) 
1.001 
(0.973 to 1.031) 
0.987          
(0.969 to 1.005) 
1.002          
(0.973 to 1.033) 
0.990          
(0.972 to 1.008) 
1.008 
(0.979 to 1.038) 
≥50 78,160 1.014 
(0.988 to 1.041) 
1.010 
(0.970 to 1.053) 
1.005          
(0.979 to 1.032) 
1.006          
(0.964 to 1.050) 
1.010 
(0.984 to 1.037) 
1.020          
(0.977 to 1.065) 
*reference category;  
#: number of participants in each noise level group included in the main analyses in Model3  
Model 3: adjusted for study, sex, age, education, employment status, smoking status and body mass index. 
Day-time (07:00-19:00); Night-time (23:00-07:00). 
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Legend 
Figure 1  
 
Associations between pan-European LUR modelled PM10 (per 10 µg/m3) and prevalence of ever-had 
asthma: subgroup analyses based on Model 3: adjusted for study, age, sex, Body Mass Index (BMI), 
smoking status, education level and employment status. 
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Supplement-1  
Pan-European LUR model methods 
NO2 and PM10 annual estimates for the year 2005-2007 were derived from a pan-European LUR 
model, which was applied on a 100m grid across Western Europe. Annual mean NO2 and PM10 data 
during 2005-2007 were obtained from over 1500 monitoring sites across Europe, regulated and 
reported by EuroAirnet. Only those monitoring sites which captured over 75% of the total hours for 
NO2 and days for PM10 were included. These monitored air pollution data were served as dependent 
variables while satellite-based ground-level concentration of NO2 and PM2.5 (both on a 10km grid) 
and GIS-derived land-use and traffic variables were served as independent variables in the LUR 
modelling.   
 NO2 
GIS-derived variables included in the final NO2 models for 2005, 2006 and 2007 across countries 
were highly consistent. Table 1 shows the variables included in the final NO2 model for the year 2007. 
For variables included in the final models for year 2005 and 2006 as well as the model equations, 
please refer to the reference paper (Vienneau, D, 2013).   
Table 1.1 GIS-variables which were included in the final Satellite-enhanced LUR model for NO2 
(year 2007) for HUNT3, LifeLines and UK Biobank 
GIS variable name Sources Description 
NO2  (year 2007) 
Constant 
  
Minor roads 1500m Central Road Network: 
EuroStreets  V3.1 
Lengths  (metre) of all minor 
roads within 1500 metre 
Major roads 100m Central Road Network: 
EuroStreets V3.1 
Lengths (metre) of all major roads 
within 100 metre 
Semi-natural land 600m CORINE Semi-natural land (% of area) 
within a 600 metre buffer 
Minor roads 1500-10000m  Central Road Network: 
EuroStreets  V3.1 
Lengths  (metre) of all minor 
roads within 1500-10,000 metre 
Total built up land 300m CORINE Total built up, % of area 
(residential, industrial, port, 
airports, mines, dumps and 
construction sites) 
3 
 
Satellite-derived surface NO2 2007 OMI (Ozone Monitoring 
Instrument)derived from 
the Aura Satellite 
Surface NO2 concentration: OMI 
derived NO2 (ppb) ~10km grid 
resolution 
 
 
 PM10 
Table 2 shows the variables inlcuded in the final PM10 model for the year 2007. For model equations, 
please refer to the reference paper (Vienneau, D, 2013).   
Table 1.2 GIS-variables included in the final Satellite-enhanced LUR model for PM10 (year 2007) for 
HUNT3, Lifelines and UK Biobank  
GIS variable name Sources Description 
PM10  (year 2007) 
Constant  
  
Minor roads 200-2500m Central Road Network: 
EuroStreets  V3.1 
Lengths  (metre) of all minor 
roads from 200-2500 metre 
Minor roads 200m Central Road Network: 
EuroStreets V3.1 
Lengths (metre) of all minor roads 
within 200 metre 
Major roads* Central Road Network: 
EuroStreets V3.1 
Lengths (metre) of all major roads 
Altitude SRTM Digital Elevation 
Database V4.1 
Altitude of the geocoded address 
Tree canopy 100m  Coarser Global land 
cover  
% of area of tree canopy within 
100 metre 
Y coordinate GIS database-ArcGIS10 Y coordinates for 100m cell 
centroids  
Satellite-derived surface PM2.5  
2001-2006 
Terra Satellite Surface PM2.5 concentration: 
Terra- derived and humidity-
corrected PM2.5 aggregated from 
2001-2006 ~10km grid resolution 
*Buffer not stated in the reference paper 
 
Reference: Vienneau D, de Hoogh K, Bechle MJ, Beelen R, van Donkelaar A, Martin RV, 
Millet DB, Hoek G, Marshall JD. Western European land use regression incorporating 
satellite- and ground-based measurements of NO2 and PM10. Environ Sci Technol 2013; 47: 
13555-13564 
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Supplement-2 
Table 2.1 Harmonised variables used as covariates in the analysis  
Harmonised name Harmonised definition Unit/Categories 
AGE_YRS Age of the participant in years 
(continuous) at recruitment  
Years 
GENDER Sex of the participant 0: Male;  1:Female 
ADM_YRINT Calendar Year of the interview calendar year 
PM_HEIGHT Measured height  cm 
PM_WEIGHT Measured weight  kg 
PM_BMI_CONTINUOUS Body Mass Index: calculated using 
measured or self-reported  weight 
and height  (kg/m2) 
kg/m2 
PM_BMI_CATEGORICAL Body Mass Index calculated using 
measured or self-reported weight 
and height (Mass in Kg / (Height in 
metre)2) and stratified in 3 
categories. 
1: less 25 kg/m2;                                 
2: 25 to 30 kg/m2;    
3: over 30 kg/m2 
SMK_STATUS Indicator of the participant's current 
and past smoking status, which 
includes use of cigarettes, cigars, 
pipes and other tobacco products. 
0: Never-smoker;         
1: Ex-smoker;          
2: Current-smoker  
WORK_STATUS_CURRENT Indicator of whether the participant 
is currently in paid employment or 
is self-employed. 
0: No paid employment or not self-
employed;          
1: Paid employment or self-
employed 
EDU_HIGHEST_1 Highest level of education 
completed by the participant. 
Categories are adapted from the 
UNESCO Revision of the 
0: No education or primary 
education        
1: Secondary education;                                    
2:Vocational/college/university  
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International Standard 
Classification of Education, 2011 
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Supplement-3  
Table 3.1 Distributions of exposures by cohort and in the pooled data  
NO2, µg/m3 N 5% 10% 25% 50% 75% 90% 95% Mean(SD) IQR 
HUNT3 50,628 8.2 8.8 10.1 11.9 15.4 18.6 19.5 13.0 (3.9) 5.3 
Lifelines 62,212 13.6 14.1 16.6 20.6 25.4 28.9 31.1 21.2 (5.7) 8.8 
UK Biobank 495,262 16.7 19.2 23.6 28.9 35 45.1 52.1 30.7 (10.7) 11.4 
Pooled 608,102 17 19.2 23.5 28.7 34.9 44.2 50.5 28.3 (9.9) 11.4 
PM10,µg/m3 N 5% 10% 25% 50% 75% 90% 95% Mean(SD) IQR 
HUNT3 50,567 9.7 10 10.4 11.2 12 12.6 12.9 11.3 (1.1) 1.6 
Lifelines 61,927 21 21.4 22.3 23.6 24.7 25.7 26.5 23.6 (1.7) 2.4 
UK Biobank 494,163 17.7 18.7 20.2 21.8 23.6 26 27.5 22.1 (2.9) 3.4 
Pooled 606,657 19.3 20.2 21.6 23.3 25 27.2 28.6 21.3 (2.7) 3.4 
LDAY, 
dB(A) 
N 5% 10% 25% 50% 75% 90% 95% Mean(SD) IQR 
HUNT3 45,644 39.1 39.5 43.6 47.4 50.3 52.9 54.6 47.0 (4.9) 6.7 
Lifelines 74,744 51.3 51.7 52.4 53.9 56.6 60.4 63.9 55.2 (4.0) 4.2 
UK Biobank 495,262 51.1 51.4 52.9 54.3 56.4 60.6 66 55.4 (4.3) 3.5 
Pooled 615,650 54.7 55.1 56.9 58.8 61.2 65.6 70.8 54.8 (4.3) 4.3 
LNIGHT, 
dB(A) 
N 5% 10% 25% 50% 75% 90% 95% Mean(SD) IQR 
HUNT3 45,644 35.1 35.2 37.5 40.2 42.5 44.8 46.4 40.3 (3.7) 5 
Lifelines 74,744 42.5 42.8 43.6 45.1 47.8 51.6 55.1 46.4 (4.0) 4.2 
UK Biobank 495,262 42.3 42.6 44 45.5 47.5 51.8 57.2 46.6 (4.3) 3.5 
Pooled 615,650 45.6 46 47.5 49.3 51.7 56.1 61.2 46.1 (4.2) 4.2 
NO2 AND PM10 were estimated based on the pan-European satellite-enhanced LUR model for year 2007 while noise estimates (LDAY and LNIGHT) were for year 2009
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Supplement-4 
Table 4.1 Spearman correlations between air pollutants and day-time noise (Lday) by cohort 
HUNT3 (N=45581) NO2 PM10 Lday   
NO2 -     
PM10 0.80 -    
Lday -0.05 0.04 -   
      
Lifelines (N=62653) NO2 PM10 NO2_ESCAPE PM10_ESCAPE Lday 
NO2 -     
PM10 0.78 -    
NO2_ESCAPE 0.86 0.78 -   
PM10_ESCAPE 0.67 0.54 0.73 -  
Lday 0.43 0.38 0.56 0.57 - 
      
UK Biobank 
(N=460,240) 
NO2 PM10 NO2_ESCAPE PM10_ESCAPE Lday 
NO2 -     
PM10 0.77 -    
NO2_ESCAPE 0.86 0.66 -   
PM10_ESCAPE 0.5 0.42 0.54 -  
Lday 0.11 0.11 0.23 0.22 - 
Correlation between Lday and Lnight (r=0.99) in each cohort.   
NO2: pan-European LUR modelled NO2 for year 2007  
PM10: pan-European LUR modelled PM10 for year 2007 
NO2_ESCAPE: ESCAPE LUR modelled NO2 for year 2010  
PM10_ESCAPE: ESCAPE LUR modelled PM10 for year 2010  
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Supplement-5 
Table 5.1 Associations (Odds ratio, 95%CI) between traffic noise and asthma prevalence: pooled 
individual-level analyses from three cohorts  
 Day-time noise 
per 5 dB(A) 
 Night-time noise 
per 5 dB(A) 
 
 Ever-had asthma 
(n=613,362) 
Current asthma 
(n=606,137) 
Ever-had asthma 
(n=613,362) 
Current asthma  
(n=606,137) 
Model 1 1.005                            
(0.996 to 1.014) 
1.000                          
(0.986 to 1.015) 
1.005                            
(0.996 to 1.015) 
1.001                           
(0.986 to 1.016) 
Model 2 1.002                          
(0.993 to 1.011) 
0.999                          
(0.985 to 1.014) 
1.002                          
(0.993 to 1.012) 
1.000                           
(0.985 to 1.015) 
Model 3 0.998                            
(0.988 to 1.008) 
0.994                          
(0.979 to 1.009) 
0.999                           
(0.989 to 1.009) 
0.995                         
(0.979 to 1.010) 
Model 3+NO2 0.996                         
(0.987 to 1.006) 
0.997                        
(0.982 to 1.013) 
0.997                         
(0.987 to 1.007) 
0.998                          
(0.983 to 1.014) 
Model 3+PM10 0.994                          
(0.984 to 1.004) 
0.992                        
(0.977 to 1.008) 
0.995                          
(0.985 to 1.005) 
0.993                          
(0.977 to 1.009) 
Model1: adjusted for study; Model 2: adjusted for study, sex, age; Model 3: further adjusted for 
education, employment status, smoking status and body mass index.  
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Supplement-6 
Table 6.1 Subgroup analyses on Model 3: Associations between pan-European LUR NO2, 
PM10 and ever-asthma prevalence  
 
 NO2,  
per 10 µg/m3 
 PM10,  
per 10 µg/m3 
 
 N Ever-had asthma  N Ever-had asthma  
Sex     
men 256,230 1.020                     
(1.007 to 1.033) 
255,655 1.131                    
(1.079 to 1.185) 
women 311,255 1.017              
(1.006 to 1.029) 
310,520 1.120                  
(1.076 to 1.166) 
P (interaction)  0.05  0.18 
Age     
<50 years 161,982 0.995                     
(0.980 to 1.010) 
161,636 1.057                     
(1.000 to 1.119) 
>=50 years 405,503 1.028                      
(1.018 to 1.038) 
404,539 1.151                     
(1.110 to 1.193) 
P (interaction)  0.13  0.01 
Smoking     
never-smoker 301,380 1.003                      
(0.991 to 1.014) 
300,698 1.073                    
(1.029 to 1.118) 
ex-smoker 195,190 1.032                    
(1.018 to 1.047) 
194,724 1.166                   
(1.108 to 1.227) 
current-smoker 70,915 1.053                    
(1.028 to 1.078) 
70,753 1.290                     
(1.178 to 1.413) 
P (interaction)  0.52  0.00 
BMI, kg/m2     
<25 194,806 1.015                   
(1.001 to 1.029) 
194,412 1.129                     
(1.071 to 1.190) 
25-30 240,402 1.016                    
(1.002 to 1.029) 
239,827 1.122                    
(1.069 to 1.177) 
>=30 132,277 1.021                   
(1.005 to 1.038) 
131,936 1.103                    
(1.040 to 1.170) 
P (interaction)  0.61  0.23 
Education     
primary school or 
less 
93,026 1.047                     
(1.024 to 1.070) 
92,814 1.195                     
(1.106 to 1.294) 
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secondary school 160,498 1.035                      
(1.017 to 1.054) 
160,085 1.227                     
(1.147 to 1.311) 
post-secondary 
school or above 
313,961 1.009                     
(0.999 to 1.019) 
313,276 1.085                    
(1.044 to 1.126) 
P (interaction)  0.53  0.00 
 
 
Table 6.2 Subgroup analyses on Model 3: Associations between pan-European LUR NO2, 
PM10 and current-asthma prevalence 
 NO2,  
per 10 µg/m3 
 PM10,  
per 10 µg/m3 
 
 N Ever-had asthma  N Ever-had asthma  
Sex     
men 252,503 0.992                      
(0.970 to 1.013) 
251,933 1.087                      
(1.004 to 1.177) 
women 308,040 0.984                  
(0.967 to 1.002) 
307,312 1.044                      
(0.979 to 1.114) 
P (interaction)  0.53  0.27 
Age     
<50 years 159,102 0.961                      
(0.937 to 0.986) 
158,758 1.016                     
(0.927 to 1.114) 
>=50 years 401,441 0.996                       
(0.980 to 1.013) 
400,487 1.071                     
(1.009 to 1.137) 
P (interaction)  0.50  0.00 
Smoking     
never-smoker 297,210 0.956                     
(0.937 to 0.973) 
296,537 0.962                     
(0.898 to 1.031) 
ex-smoker 193,028 1.023                      
(1.000 to 1.046) 
192,575 1.175                     
(1.080 to 1.278) 
current-smoker 70,295 1.022                     
(0.983 to 1.062) 
70,133 1.231                      
(1.064 to 1.424) 
P (interaction)  0.34  0.00 
BMI, kg/m2     
<25 192,194 0.981                      
(0.958 to 1.005) 
191,806 1.036                     
(0.948 to 1.131) 
25-30 237,402 0.972                       
(0.951 to 0.994) 
236,830 1.045                     
(0.964 to 1.133) 
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>=30 130,947 1.010                     
(0.985 to 1.036) 
130,609 1.096                     
(0.998 to 1.203) 
P (interaction)  0.33  0.24 
Education     
primary school or 
less 
92,476 1.018                      
(0.983 to 1.055) 
92,265 1.118                      
(0.988 to 1.267) 
secondary school 159,132 1.028                       
(0.998 to 1.058) 
158,722 1.205                     
(1.083 to 1.341) 
post-secondary 
school or above 
308,935 0.968                      
(0.951 to 0.985) 
308258 1.004                     
(0.943 to 1.071) 
P (interaction)  0.30  0.00 
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Supplement-7 
Table 7.1 Sensitivity analyses: restricting analyses to those living at the same address for 
more than 10 years, adjusting for study, age, sex, BMI, smoking, education, employment 
status.  
NO2, per 10 µg/m3  PM10, per 10 µg/m3 
N Ever-had 
asthma  
N Current 
asthma      
N Ever-had 
asthma  
N Current 
asthma   
376,191 1.026         
(1.015 to 
1.037) 
371,969 0.988         
(0.971 to 
1.005) 
375,387 1.163         
(1.120 to 
1.208) 
371174 1.074        
(1.009 to 
1.143) 
Day-time noise, per 5 dB(A) Night-time noise,  per 5 dB(A) 
N Ever-had 
asthma  
N Current 
asthma   
N Ever-had 
asthma  
N Current 
asthma   
379,794 1.005         
(0.993 to 
1.018) 
375,572 1.007         
(0.988 to 
1.026) 
379,794 1.006          
(0.993 to 
1.019) 
375,572 1.009         
(0.988 to 
1.028) 
 
 
Table 7.2 Sensitivity analyses: Using ESCAPE-LUR modelled NO2 and PM10 for LifeLines 
and UK Biobank and pan-European LUR modelled NO2 and PM10 for HUNT3 in the pooled 
analyses, adjusting for study, age, sex, BMI, smoking, education, employment status.  
NO2, per 10 µg/m3 PM10, per 10 µg/m3 
N Ever-had 
asthma  
N Current 
asthma      
N Ever-had 
asthma  
N Current 
asthma   
567,485 1.023                
(1.011 to 
1.035) 
560,543 1.019         
(1.000 to 
1.038) 
534,347 1.071          
(1.021 to 
1.123) 
527,733 1.114         
(1.030 to 
1.204) 
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Supplementary Figure 1  
 
Supplementary Figure 1 Associations between pan-European LUR NO2 (per 10 µg/m3), PM10 (per 10 
µg/m3), daytime noise (LDAY, per 5 dB(A)) and  ever-had asthma prevalence: study-specific meta-
analyses based on model 3 (adjusted for, age, sex, BMI, smoking status, education level and 
employment status).  
ES: Effect estimate 
I-squared: variation in estimated effect attributable to heterogeneity  
I-V: inverse-variance weighted (fixed effect model) 
D+L: DerSimonian and Laird (random effect model) 
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Supplementary Figure 2 
 
 
Supplementary Figure 2 Associations between pan-European LUR NO2 (per 10 µg/m3), PM10 (per 10 
µg/m3), day-time noise (LDAY, per 5 dB(A)) and current-asthma prevalence: study-specific meta-
analyses based on model 3 (adjusted for age, sex, BMI, smoking status, education level and 
employment status).  
ES: Effect estimate 
I-squared: variation in estimated effect attributable to heterogeneity  
I-V: inverse-variance weighted (fixed effect model) 
D+L: DerSimonian and Laird (random effect model) 
 
